Improved survival in medically-treated chronic thromboembolic pulmonary hypertension

R. Nishimura, N. Tanabe, Y. Ichimura, A. Sekine, T. Sugiura, T. Jujo, A. Shigeta, S. Sakao, Y. Kasahara, Y. Takiguchi, K. Tatsumi (Chiba, Japan)

Source: Annual Congress 2011 - Treatment of human pulmonary hypertension
Session: Treatment of human pulmonary hypertension
Session type: Thematic Poster Session
Number: 2287
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Nishimura, N. Tanabe, Y. Ichimura, A. Sekine, T. Sugiura, T. Jujo, A. Shigeta, S. Sakao, Y. Kasahara, Y. Takiguchi, K. Tatsumi (Chiba, Japan). Improved survival in medically-treated chronic thromboembolic pulmonary hypertension. Eur Respir J 2011; 38: Suppl. 55, 2287

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Predictors of poor outcome in chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism
Year: 2012


Longterm survival of inoperable chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2008 - Acute and chronic pulmonary thromboembolic disease
Year: 2008


The impact of patient choice on survival in chronic thromboembolic pulmonary hypertension
Source: Eur Respir J, 52 (3) 1800589; 10.1183/13993003.00589-2018
Year: 2018



The impact of immediate postoperative pulmonary vascular resistance on survival in patients with chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2009 - Pulmonary embolism
Year: 2009

Incidence of chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism
Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism
Year: 2011


Adherence to disease-specific drug treatment among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
Source: ERJ Open Res, 6 (4) 00299-2020; 10.1183/23120541.00299-2020
Year: 2020



Survival in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Eur Respir J 2005; 26: Suppl. 49, 272s
Year: 2005

Incidence of recurrent thromboembolism and chronic thromboembolic pulmonary hypertension after pulmonary embolism
Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism
Year: 2011

Analysis of mortality risk factors in a population with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010


Survival in medically treated chronic thromboembolic pulmonary hypertension patients
Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension
Year: 2018



Impact of two 5-year anticoagulant strategies on survival and echocardiographic parameters in the patients with chronic thromboembolic pulmonary hypertension (CTEPH) who did not undergo pulmonary endarterectomy
Source: Annual Congress 2004 - Pulmonary embolism
Year: 2004


Comparison of clinical characteristics in patients with pulmonary arterial hypertension and inoperable chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008

Prevalence of chronic thromboembolic pulmonary hypertension 2 years after pulmonary embolism
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008


Factors associated with survival in patients with not-operated chronic thromboembolic pulmonary hypertension (CTEPH) in the modern management era
Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension
Year: 2018



Frequency of chronic thromboembolic pulmonary hypertension screening after pulmonary embolism in cancer patients.
Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies
Year: 2018



Survival in patients with chronic thromboembolic pulmonary hypertension in the modern management era
Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension
Year: 2020


Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Eur Respir J, 53 (6) 1802004; 10.1183/13993003.02004-2018
Year: 2019



Chronic thromboembolic pulmonary hypertension
Source: International Congress 2015 – ME5 Chronic thromboembolic pulmonary hypertension
Year: 2015




Chronic thromboembolic pulmonary hypertension
Source: International Congress 2018 – State of the art session: Pulmonary vascular diseases
Year: 2018


Chronic thromboembolic pulmonary hypertension
Source: International Congress 2017 – Russian Programme 2017
Year: 2017